SOUTH SAN FRANCISCO, CA, Link Cell Therapies, an oncology cell therapy company, announced its official launch from stealth with a $60 million Series A financing.
Link Cell Therapies, an oncology cell therapy company, announced its official launch from stealth with a $60 million Series A financing that was led by Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation - JJDC, Inc. , with participation from founding investors Samsara BioCapital and Sheatree Capital, as well as Wing Venture Capital and other new strategic and financial investors.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
